| ASSET | YEAR | % RETURN |
|---|---|---|
Inozyme Pharma (INZY) | 2020 | -0.77% |
Inozyme Pharma (INZY) | 2021 | -68.31% |
Inozyme Pharma (INZY) | 2022 | -84.6% |
Inozyme Pharma (INZY) | 2023 | 264.1% |
Inozyme Pharma (INZY) | 2024 | -34.52% |
Inozyme Pharma (INZY) | 2025 | -62.28% |
